FRIDAY, Sept. 14, 2018 — For patients undergoing rhinoplasty, postoperative opioid refills are extremely rare, according to a research letter published online Sept. 6 in JAMA Facial Plastic Surgery. Rosh K.V. Sethi, M.D., M.P.H., from Harvard Medical School in Boston, and colleagues conducted a retrospective review of 173 patients who underwent rhinoplasty to examine opioid […]Continue Reading ...
As one of the most common malignant tumors, gastric cancer (GC) occupies the second leading cause of cancer-related deaths worldwide with an increasing trend. The reduced physiological function and low immunity in elderly patients with gastric cancer leads to a significantly increased incidence of postoperative complications. In addition, postoperative complications among elderly patients are usually […]Continue Reading ...
In a new analysis of data submitted to Maryland’s state trauma registry from 2005 to 2017, Johns Hopkins Medicine researchers found that gunshot victims are approximately five times more likely to require blood transfusions, they require 10 times more blood units and are 14 times more likely to die than people seriously injured by motor […]Continue Reading ...
Two variants of an autoimmune disease that affects thousands but is hard to diagnose are relatively common among black Africans, research shows. The findings, relating to systemic lupus erythematosus, or SLE, could improve diagnosis and treatment of the condition. They could enable better management of the disease in patients of African descent, particularly in southern […]Continue Reading ...
The research was conducted over a period of six months with a group of 36 patients in the Hemodialysis Unit of the General University Hospital of Alicante and three nurses who had received training in solution-focused communication. The study, conducted in collaboration with María del Carmen Neipp (Miguel Hernández University of Elche), Maite García-Moreno (Hospital […]Continue Reading ...
HIV infecting a human cell. Credit: NIH In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection. Used in combination with existing HIV medications, the drug is a promising strategy for patients who have run out of effective treatment options, the researchers said. The […]Continue Reading ...
CRANBURY, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare metabolic diseases, announced today regulatory and clinical advancements in its development program AT-GAA for Pompe disease. During the third quarter, Amicus held a Type C meeting with the United […]Continue Reading ...
Patients with chronic lymphocytic leukemia (CLL) who feel more stress also have more cancer cells in their blood and elevated levels of three other markers of more advanced disease. A new study of 96 patients is the first to link stress with biological disease markers in patients with CLL. “All four variables we measured are […]Continue Reading ...
Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 Chronic Obstructive Pulmonary Disease (COPD) patients treated with Spiolto® (tiotropium/olodaterol) Respimat®, which were presented today at the European Respiratory Society (ERS) International Congress 2018 in Paris, France. Patients in the study reported both improved physical functioning and general condition and […]Continue Reading ...
Results from INPULSIS®-ON, published today in Lancet Respiratory Medicine, provide insights into the long-term safety, efficacy and tolerability of Ofev® (nintedanib) in patients with idiopathic pulmonary fibrosis (IPF). These data suggest that the effect of nintedanib on slowing disease progression of IPF persists beyond four years.1 Results also indicate that the long-term efficacy of nintedanib […]Continue Reading ...
Patients with severe traumatic brain injury treated at Helsinki University Hospital, Finland, recover to functional independence more often than before. At the same time, the proportions of elderly patients and patients treated conservatively have increased. The study found no specific reason to explain the observed improvement in outcomes; the results are accounted for by improvements […]Continue Reading ...
South San Francisco, CA — September 13, 2018 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved the subcutaneous (SC) formulation of Actemra (tocilizumab) for the treatment of active systemic juvenile idiopathic arthritis (SJIA) in patients two years of […]Continue Reading ...
Credit: CC0 Public Domain Ardelyx, Inc. today announced that the novel mechanism of action for tenapanor for the treatment of hyperphosphatemia, or elevated serum phosphorus, has been published in the peer-reviewed journal Science Translational Medicine. Tenapanor is a sodium/hydrogen exchanger 3 (NHE3) inhibitor currently being evaluated in a second Phase 3 registration trial, the PHREEDOM […]Continue Reading ...
Children who experience some type of adverse event following initial immunization have a low rate of recurrent reactions to subsequent vaccinations, reports a study in The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer. “Most patients with […]Continue Reading ...
September 06, 2018 — Breda, the Netherlands / Ghent, Belgium – argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer, today announced the dosing of the first patient in a global Phase 3 registration trial of efgartigimod (ARGX-113) […]Continue Reading ...
- FDA-approved ‘safe’ daily BPA exposure may contribute to insulin resistance
- Research finds physical connection between the brain’s fluid reservoirs and meningeal lymphatics
- Biomedical review finds failure rates in some surgical mesh treatments to be unacceptably high
- Researchers develop more accurate measure of body fat
- Doctors and students rally to support gun violence research, education
- LEO Pharma and MorphoSys announce expansion of strategic alliance to develop peptide-derived drugs
- Seniors in pain hop aboard the canna-bus
- New compound could prevent malaria parasites from maturing inside mosquito
- Scientists find alterations in blood flow in response to body position change
- UNC Health Care extends free access to virtual care service in the aftermath of Hurricane Florence
- Opioid Refills Rare After Rhinoplasty
- Corn, obesity, and navigating healthy eating choices as a parent
- Journal editor aims to prompt thoughtful review of ethics in precision health
- Researchers identify key step in how plant cells respond to pathogens
- Researchers analyze how exposure to silver nanoparticles affects zebrafish
- Study shows air pollution may be bad for the fetus
- Coffee May Have Another Perk for Kidney Patients
- Tongue-in-cheek Nobels honor nutritional analysis of cannibalism, roller-coaster kidney stones treatment
- Progress, priorities, challenges are focus of State of Stanford Medicine | News Center
- Established Alzheimer’s Risk Gene Has a New Role